|
|
原发性睾丸弥漫大B细胞性淋巴瘤病例报告及文献复习
|
Abstract:
原发性睾丸淋巴瘤(PTL)是一种罕见且具有侵袭性的结外淋巴瘤，可分为原发和继发两类。1) 原发性：以睾丸肿块为原发症状或主要症状，无其他结外器官受累，经病理确诊为DLBCL。2) 继发性：系统性累及睾丸的DLBCL为继发睾丸DLBCL，以原发性常见。目前PTl-DLBCL的相关文献报道较少且发病机制未明，推荐的综合治疗方案仍存在较高的结外复发风险。
Primary Testicular Lymphoma (PTL) is a rare and invasive extranodal lymphoma, which can be divided into primary and secondary types. 1) Primary: Testicular mass is the primary symptom or the main symptom without other extranodal organ involvement, which is pathologically diagnosed as DLBCL. 2) Secondary: DLBCL with systemic involvement of the testis is secondary testicular DLBCL, which is common in primary. At present, there are few reports on PTl-DLBCL and the pathogenesis is unknown. The recommended comprehensive treatment still has a high risk of extranodal recurrence.
| [1] | Cheah, C.Y., Wirth, A. and Seymour, J.F. (2014) Primary Testicular Lymphoma. Blood, 123, 486-493. https://doi.org/10.1182/blood-2013-10-530659 |
| [2] | Vitolo, U., Seymour, J.F., Martelli, M., Illerhaus, G., Illidge, T., Zucca, E., et al. (2016) Extranodal Diffuse Large B-Cell Lymphoma (DLBCL) and Primary Mediastinal B-Cell Lymphoma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 27, v91-v102. https://doi.org/10.1093/annonc/mdw175 |
| [3] | Zhang, J., Zhang, Y. and Luo, C. (2024) Clinical, Pathological and Immunohistochemical Characteristics of Patients with Primary Testicular Lymphoma Undergoing Orchiectomy: A Systematic Review and Meta-Analysis. Archivos Españoles de Urología, 77, 505-516. https://doi.org/10.56434/j.arch.esp.urol.20247705.70 |
| [4] | Fonseca, R., Habermann, T.M., Colgan, J.P., O’Neill, B.P., White, W.L., Witzig, T.E., et al. (2000) Testicular Lymphoma Is Associated with a High Incidence of Extranodal Recurrence. Cancer, 88, 154-161. https://doi.org/10.1002/(sici)1097-0142(20000101)88:1<154::aid-cncr21>3.0.co;2-t |
| [5] | Conconi, A., Chiappella, A., Ferreri, A.J.M., Stathis, A., Botto, B., Sassone, M., et al. (2024) IELSG30 Phase 2 Trial: Intravenous and Intrathecal CNS Prophylaxis in Primary Testicular Diffuse Large B-Cell Lymphoma. Blood Advances, 8, 1541-1549. https://doi.org/10.1182/bloodadvances.2023011251 |
| [6] | Vitolo, U., Chiappella, A., Ferreri, A.J.M., Martelli, M., Baldi, I., Balzarotti, M., et al. (2011) First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma with Rituximab-Chop, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial. Journal of Clinical Oncology, 29, 2766-2772. https://doi.org/10.1200/jco.2010.31.4187 |
| [7] | Bart, J., Groen, H.J., van der Graaf, W.T., Hollema, H., Hendrikse, N.H., Vaalburg, W., et al. (2002) An Oncological View on the Blood-Testis Barrier. The Lancet Oncology, 3, 357-363. https://doi.org/10.1016/s1470-2045(02)00776-3 |
| [8] | Seymour, J.F., Solomon, B., Wolf, M.M., Janusczewicz, E.H., Wirth, A. and Prince, H.M. (2001) Primary Large-Cell Non-Hodgkin’s Lymphoma of the Testis: A Retrospective Analysis of Patterns of Failure and Prognostic Factors. Clinical Lymphoma, 2, 109-115. https://doi.org/10.3816/clm.2001.n.016 |
